Most prescriptions in the United States are filled with mass-produced medications — identical tablets pressed by the millions in factories. Compounded medications take the opposite route: a licensed pharmacist prepares each one for a single, named patient, working from that patient's prescription. This guide walks through how compounded medications are made — who is allowed to make them, the rules they work under, what happens between prescription and finished preparation, and how the result differs from what comes off a production line.

What pharmaceutical compounding is

The U.S. Food and Drug Administration describes compounding as a practice in which a licensed pharmacist, a licensed physician, or a person supervised by a licensed pharmacist combines, mixes, or alters the ingredients of a drug to create a medication tailored to the needs of an individual patient. The key word is individual: a compounded preparation is not pulled from a warehouse shelf. It exists because a specific prescriber wrote a prescription for a specific person, and it is prepared with that person's strength, dosage form, and ingredients in mind.

Compounding is a long-standing, legal part of American pharmacy practice, and it is regulated — just through a different pathway from FDA approval. Federal law sets the conditions under which pharmacies may compound; state boards of pharmacy license and inspect the pharmacies themselves; and pharmacopeial standards govern the day-to-day technique. Compounded medications are not FDA-approved, which means FDA does not review each preparation for safety, effectiveness, or quality before it reaches a patient — a point FDA makes plainly in its compounding Q&A, and one worth understanding rather than glossing over.

What a 503A compounding pharmacy is

Most patient-specific compounding happens in what federal law calls a 503A pharmacy — named for Section 503A of the Federal Food, Drug, and Cosmetic Act. Section 503A describes the conditions a state-licensed pharmacy must meet to compound: the work must be done by or under the supervision of a licensed pharmacist, and — centrally — each preparation must be made against a valid, patient-specific prescription. A 503A pharmacy is licensed by its state, and state boards of pharmacy carry primary responsibility for its day-to-day oversight, including inspections. Federal law still applies on top: FDA conducts surveillance and for-cause inspections, and provisions against preparing drugs under insanitary conditions apply to every setting where compounding happens.

A second category, 503B “outsourcing facilities,” registers directly with FDA, follows manufacturing-grade quality rules, and compounds in larger batches — mostly for hospitals and clinics. The pharmacy filling an individual patient's prescription is typically a 503A pharmacy.

The compounding pharmacy process, step by step

The compounding pharmacy process runs, in broad strokes, like this:

  1. A prescription arrives. Everything starts with a licensed prescriber writing a prescription for a named patient. Under Section 503A, that patient-specific prescription is what authorizes the pharmacy to compound at all.
  2. The pharmacy pulls its formulation record. For each preparation it makes, a pharmacy maintains a master formulation record — the recipe, in effect: ingredients and amounts, equipment, mixing steps, quality checks, storage conditions, and how the beyond-use date is assigned.
  3. Ingredients are verified. Active pharmaceutical ingredients arrive with documentation such as certificates of analysis, and are logged, stored, and checked before use.
  4. The preparation is made. Non-sterile preparations — capsules, creams, oral liquids — are compounded in a controlled workspace. Sterile preparations, such as injectables, are made in cleanroom conditions using aseptic technique: filtered air, gowning, disinfected surfaces, and movements designed to keep the preparation untouched by anything unsterile.
  5. A pharmacist checks the work. Verification runs through the whole process — weights double-checked, the finished preparation inspected, and, depending on the preparation and state requirements, samples tested. Sterility, endotoxin, and potency testing are common examples for injectables.
  6. It is labeled and dispensed. The finished preparation carries a patient-specific label with the drug, strength, directions, storage instructions, and a beyond-use date — the date after which it should not be used.

The quality standards behind the work

The technique in that process is not improvised. The United States Pharmacopeia (USP) publishes the standards that define good compounding practice: General Chapter 795 covers non-sterile preparations, Chapter 797 covers sterile preparations, and Chapter 800 addresses safe handling of hazardous drugs. These chapters specify training, facilities, air quality, cleaning, documentation, and how beyond-use dates are assigned. Many states expect compounders to adhere to USP's standards of practice, writing the chapters into their own pharmacy regulations — which is how a pharmacopeia becomes enforceable law, state by state.

When clinicians turn to compounded formulations

FDA's own examples are the clearest: a patient allergic to a dye needs the medication made without it; an older adult or a child who cannot swallow a tablet needs a liquid; a needed strength is not commercially available. Compounding also covers molecules that are available in the U.S. only as compounded preparations — many prescription peptides fall into this category.

That is how the products on this site work. Sermorelin, for example, is dispensed as a compounded medication, which is different from an FDA-approved product: the formulation offered here is not FDA-approved. The same per-prescription model applies across the catalog, from BPC-157 to the metabolic therapies: you complete an online visit, a licensed provider reviews every request, and the prescription is sent to a licensed U.S. compounding pharmacy that prepares the medication for you.

How compounding differs from mass manufacturing

A manufactured drug is produced in large batches, in facilities registered with FDA and operating under current good manufacturing practice (CGMP), and the product itself goes through premarket review before it can be marketed. A compounded preparation inverts nearly every one of those terms: it is made one prescription at a time, in a state-licensed pharmacy, under USP-informed technique rather than CGMP, and without premarket review — compounded preparations are not FDA-approved. What manufacturing standardizes at population scale, compounding tailors at the scale of one patient.

Neither route is casual about quality — they distribute responsibility differently. With a compounded medication, the prescriber's clinical judgment, the pharmacy's state licensure, and USP-grounded practice together do the work that premarket review does for a manufactured product. That is why the honest version of this story includes both halves: compounding is legal, regulated, and professionally standardized — and it asks more of the prescribing decision. If you are considering a compounded therapy, the right first step is the same as for any prescription: talk it through with a licensed provider.